GenoGenix LLC recalls NAD+ (Nicotinamide adenine dinucleotide) for Injection, a) 100 mg/mL b) 200 mg/mL, 10 mL multi-dose amber vials, GenoGe…

Recall date

July 30, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0094-2026

FDA classification

Class I

Brand / firm

GenoGenix LLC

Sold / distributed

US Nationwide.

Why it was recalled

Microbial Contamination of Sterile Products: elevated endotoxin levels

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

NAD+ (Nicotinamide adenine dinucleotide) for Injection, a) 100 mg/mL b) 200 mg/mL, 10 mL multi-dose amber vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.